ProJenX, Inc.
PrivateLast Round
Grant
Jun 20, 2024
Total Funding Raised
$21.1M
Company Overview
ProJenX, Inc. is a biotechnology company that develops novel, brain-penetrant, targeted therapies for the treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProJenX, Inc. Comparables
Compare ProJenX, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QurAlis | 84% | |
| Trace Neuroscience | 82% | |
| Spinogenix, Inc. | 82% | |
ProJenX, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 20, 2024 | ||||
| Series A | Nov 2, 2023 | ||||
| Seed | Feb 16, 2022 |
Key People
Founding team and executive leadership
ProJenX, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| Medical Excellence Capital | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2024
$1M grant received from The ALS Association.
ProJenX, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ProJenX, Inc.'s valuation, stock price, and market status.